Cancer52 has released its latest report on health inequalities , as part of the Big Cancer52 Conversation event. >> Read report...

Fair Market Value (FMV) Guidance is now available to bring consistency to reimbursement for cross-sector partnership work. See FMV...

Cancer52 has prepared a briefing for a Westminster Hall Debate  on the ‘Potential merits of a cancer strategy for England’ . The debate...

We are delighted to welcome a new member! The Sophie Fitzpatrick Charitable Foundation for Rare Cancers.

Patient Organisation Statement on NHS England Commercial Framework Consultation

Interim CEO, Sasha Daly was pleased to meet with Minister Andrew Gwynne to talk through cancer services and how Cancer52 can work in partner

Cancer52 is delighted to announce the appointment of Chris Walden as our new CEO.

Longstanding CEO, Jane Lyons stepped down on Monday 15th July. Sasha Daly , Director for Policy at Cancer52, is Interim CEO during the...

Cancer52 has launched a manifesto called   ‘The Other Half. A manifesto to transform outcomes for people with rare and less common...

Cancer52 recently hosted The Big Cancer52 Conversation at Level39 in Canary Wharf. This was the third Big Cancer52 Conversation, and...